Formed around the lab of Professor Ben Davis, Director of Next Generation Chemistry at The Franklin, the partnership will see bilateral movement of researchers between the Franklin and Oxford, widening access to the cutting edge facilities at Harwell.
Professor Frances Platt, Head of Department at the University of Oxford Department of Pharmacology said, “I am delighted that Professor Davis will be joining our department – his research is an excellent fit with existing work taking place in Pharmacology. This partnership with The Franklin offers a wealth of opportunity for our research and academic staff to form exciting new collaborations with world-leading scientists and facilities.”
One of the key aims for the Davis group is to perform ‘in-cell chemistry’ – editing proteins and other biomolecules within the cell for therapeutic or diagnostic purposes. This work is revolutionary in its approach, and is highly complementary to other Franklin themes, including mass spectrometry imaging, structural biology, and correlated imaging.